Current Neuropharmacology
Volume 19, 12 Issues, 2021
ISSN: 1875-6190 (Online)
ISSN: 1570-159X (Print)
This journal supports open access
ISSN: 1875-6190 (Online)
ISSN: 1570-159X (Print)
This journal supports open access
Most Accessed Articles
Crocus Sativus L. (Saffron) in Alzheimer’s Disease Treatment: Bioactive Effects on Cognitive Impairment
, 2021; 19(9): 1606-1616.Grazia D’Onofrio*, Seyed Mohammad Nabavi, Daniele Sancarlo, Antonio Greco and Stefano Pieretti
DOI: 10.2174/1570159X19666210113144703
5-HT3 Receptor Antagonism: A Potential Therapeutic Approach for the Treatment of Depression and other Disorders
, 2021; 19(9): 1545-1559.Shvetank Bhatt*, Thangaraj Devadoss, Santhepete Nanjundaiah Manjula and Jayaraman Rajangam
DOI: 10.2174/1570159X18666201015155816
Adolescent Substance Abuse, Transgenerational Consequences and Epigenetics
, 2021; 19(9): 1560-1569.Hamed Salmanzadeh , S. Mohammad Ahmadi-Soleimani, Maryam Azadi, Robert F. Halliwell* and Hossein Azizi *
DOI: 10.2174/1570159X19666210303121519
Targeting Brain-spleen Crosstalk After Stroke: New Insights Into Stroke Pathology and Treatment
, 2021; 19(9): 1590-1605.Dong Han, Hang Liu, Yan Gao and Juan Feng*
DOI: 10.2174/1570159X19666210316092225
The Multifaceted Therapeutic Role of N-Acetylcysteine (NAC) in Disorders Characterized by Oxidative Stress
, 2021; 19(8): 1202-1224.Ganesh Raghu, Michael Berk, Peter A. Campochiaro, Hartmut Jaeschke, Giancarlo Marenzi, Luca Richeldi, Fu-Qiang Wen, Ferdinando Nicoletti and Peter M. A. Calverley*
DOI: 10.2174/1570159X19666201230144109
Gut Microbiota Regulate Astrocytic Functions in the Brain: Possible Therapeutic Consequences
, 2021; 19(8): 1354-1366.Ya-Fei Zhao, Da-Neng Wei and Yong Tang*
DOI: 10.2174/1570159X19666210215123239
The Brain-gut Axis-where are we now and how can we Modulate these Connections?
, 2021; 19(8): 1164-1177.Wojciech Dabrowski*, Dorota Siwicka-Gieroba, Katarzyna Kotfis, Sami Zaid, Sylwia Terpilowska, Chiara Robba and Andrzej K. Siwicki
DOI: 10.2174/1570159X18666201119155535
Recent Evidence in Epigenomics and Proteomics Biomarkers for Early and Minimally Invasive Diagnosis of Alzheimer’s and Parkinson’s Diseases
, 2021; 19(8): 1273-1303.Sonia Mayo*, Julián Benito-León, Carmen Peña-Bautista, Miguel Baquero and Consuelo Cháfer-Pericás*
DOI: 10.2174/1570159X19666201223154009
Immune Checkpoint Inhibitors and Neurotoxicity
, 2021; 19(8): 1246-1263.Zhiyi Zhao, Chunlin Zhang, Lian Zhou, Pan Dong* and Lei Shi*
DOI: 10.2174/1570159X19666201230151224
The Management and Alternative Therapies for Comorbid Sleep Disorders in Epilepsy
, 2021; 19(8): 1264-1272.Weifeng Peng, Jing Ding* and Xin Wang
DOI: 10.2174/1570159X19666201230142716
The Endocannabinoid System as Modulator of Exercise Benefits in Mental Health
, 2021; 19(8): 1304-1322.Sandra Amatriain-Fernández, Henning Budde, Thomas Gronwald, Carla Quiroga, Cristina Carreón, Gerardo Viana-Torre, Tetsuya Yamamoto, Claudio Imperatori, Sérgio Machado and Eric Murillo-Rodríguez*
DOI: 10.2174/1570159X19666201218112748
The Investigation into Neurotoxicity Mechanisms of Nonylphenol: A Narrative Review
, 2021; 19(8): 1345-1353.Mandana Lotfi, Amir Hosseyn Hasanpour, Ali Akbar Moghadamnia and Sohrab Kazemi*
DOI: 10.2174/1570159X18666201119160347
The Neuroprotective Role of Neuroserpin in Ischemic and Hemorrhagic Stroke
, 2021; 19(8): 1367-1378.Shanshan Ding, Qiliang Chen, Huaqin Chen, Bangshui Luo, Candong Li, Liang Wang and Tetsuya Asakawa*
DOI: 10.2174/1570159X18666201008113052
Therapeutic Potential of Multifunctional Derivatives of Cholinesterase Inhibitors
, 2021; 19(8): 1323-1344.Maja Przybyłowska, Krystyna Dzierzbicka, Szymon Kowalski, Klaudia Chmielewska and Iwona Inkielewicz-Stepniak*
DOI: 10.2174/1570159X19666201218103434
Interplay of BDNF and GDNF in the Mature Spinal Somatosensory System and Its Potential Therapeutic Relevance
, 2021; 19(8): 1225-1245.Francesco Ferrini, Chiara Salio, Elena M. Boggio and Adalberto Merighi*
DOI: 10.2174/1570159X18666201116143422
Building Resilience with Aerobic Exercise: Role of FKBP5
, 2021; 19(8): 1156-1160.P. Sampedro-Piquero* and R.D. Moreno-Fernández*
DOI: 10.2174/1570159X19666210408124937
Sceletium for Managing Anxiety, Depression and Cognitive Impairment: A Traditional Herbal Medicine in Modern-Day Regulatory Systems
, 2021; 19(9): 1384-1400.Thomas Brendler*, Josef A. Brinckmann, Ulrich Feiter, Nigel Gericke, Lucy Lang, Olga N. Pozharitskaya, Alexander N. Shikov, Michael Smith and Ben-Erik Van Wyk
DOI: 10.2174/1570159X19666210215124737
Neuroprotective Potential of Caffeic Acid Phenethyl Ester (CAPE) in CNS Disorders: Mechanistic and Therapeutic Insights
, 2021; 19(9): 1401-1415.Namrata Pramod Kulkarni, Bhupesh Vaidya, Acharan S. Narula and Shyam Sunder Sharma*
DOI: 10.2174/1570159X19666210608165509
Editor-in-Chief
Ferdinando Nicoletti
Department of Pharmaceutical Sciences
University Rome"da Sapienza"
Rome
(Italy)
Department of Pharmaceutical Sciences
University Rome"da Sapienza"
Rome
COPE Compliant
About the Journal
For Authors
For Librarians & Readers
Quick Links
Journal History
Current Neuropharmacology was introduced in 2003 and Dr. Ferdinando Nicoletti is the New Editor-in-Chief of the journal, appointed in 2019.
New eBook
 |
Neurobiology of Mood DisordersYou can view the contents of this eBook [here] or purchase it [here]. |
Advertisement
Webmaster Contact: info@benthamscience.net